Keyword: DSM

Chemistry & Life Sciences

Investing in Growth Through Innovation

17.10.2022 -

Interview with Marc Doyle, CEO of Arxada, which was created following the carve-out and sale of Lonza Specialty Ingredients to private equity firms Bain Capital and...


Bachem Buys DSM’s Sisslerfeld Site

10.10.2022 -

Swiss peptide and oligonucleotide specialist Bachem has agreed to buy an undeveloped site in Sisslerfeld from DSM. It has completed the purchase of a first plot, with...


Calum MacLean to Head Lanxess-Advent JV

19.09.2022 -

German specialty chemicals producer Lanxess and private equity group Advent International have named Calum MacLean as CEO-designate of their planned joint venture for...


Technip Energies Buys DSM’s Biosuccinium Technology

05.09.2022 -

French engineering and technology company Technip Energies has boosted its sustainable chemicals portfolio with the purchase of DSM’s biosuccinium technology. Financial...


Arxada Expands at Visp to Continue Supplying DSM

26.08.2022 -

Swiss specialty chemicals company Arxada said it will invest 20 million Swiss francs to expand production at its Visp site following the extension of a long-term supply...


DSM to Buy Brazil’s Prodap

10.06.2022 -

DSM has entered into an agreement to buy Prodap, a Brazilian animal nutrition and technology company. The deal remains subject to customary conditions and is expected to...


Repsol Builds Iberia’s First UHMWPE Plant

09.06.2022 -

Repsol has announced plans to invest €105 million to build a plant for ultra-high molecular weight PE (UHMWPE) at its Puertollano complex in Spain. The company said the...


Firmenich-DSM Merger to Create Sector Giant

02.06.2022 -

In an M&A market that is heating up, one mega deal begets another, as market watchers speculate on what the next big move might be, when it might come and which players...